
Brain mapping is called a QEEG, which stands for Quantitative Electroencephalogram. Put simply, an electrical recording is done by attaching sensors to the scalp and the raw EEG (brain data) is converted into brain maps. Brain Maps allow the client to see what areas are dysregulated in the brain, and when correlated with current symptoms, which areas of the brain are trainable using neurofeedback.
No. A QEEG brain mapping assessment is not the same as a clinical EEG used for diagnosing medical conditions such as epilepsy or brain tumors. Brain mapping is designed to assess how the brain is functioning, not to diagnose medical pathology. At Reboot, QEEG is used solely as a tool to guide neurofeedback and support functional brain regulation.
Neurofeedback is biofeedback using your own brain waves as a learning tool. The client receives visual (games) and auditory (music or tones) feedback as to whether they are producing the correct brainwave patterns that reduce symptoms. Neurofeedback corrects the underlying issues in brain patterns often reducing or eliminating the need for medication.
During a neurofeedback session, sensors are placed on the scalp to read brain activity — no electrical current is ever put into the brain. A short baseline recording is taken, and the data is analyzed to determine which areas of the brain need training based on your symptoms. You then relax and watch a screen or listen to sounds while the software provides feedback. Over time, the brain learns which patterns are more effective and begins to regulate itself more efficiently.
While improvement cannot be guaranteed due to the many variables involved in healing and transformation, research supports the effectiveness of neurofeedback, and many individuals experience meaningful benefits. Progress varies from person to person, and results depend on factors such as brain patterns, consistency, and individual circumstances.
Neurofeedback has been approved by the FDA for stress reduction. However, its use for treating specific medical conditions is still considered experimental. Although not fully FDA-approved for all conditions, there is a substantial and growing body of research supporting its effectiveness. The medical system traditionally prioritizes medication and surgery, which plays a role in FDA classifications.
Neurofeedback is non-invasive and considered very safe. No electrical current is introduced into the brain. Side effects are rare and usually mild. Some individuals may feel temporarily tired, spacey, experience mild headaches, or notice changes in sleep patterns during the early stages of training. These effects typically resolve as the brain adjusts and are often a sign that regulation is occurring.
While some individuals notice improvements within the first few sessions, neurofeedback usually requires 30-40 sessions for more lasting change. We generally expect to see some response within the first 15 sessions if neurofeedback is a good fit. Some clients choose to continue with occasional “tune-up” sessions after completing their initial training.
© 2026 Reboot | MC Digital Creatives